+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 10011
Bookmarks
Interleukin 11 - An overview.
Interleukin 12.
Interleukin 12 (IL-12) increased tumour bearing human liver expands CD8+ CD56+ T cells vitro vivo.
Interleukin 12 (IL12B) interleukin 12 receptor (IL12RB1) gene polymorphisms rheumatoid arthritis.
Interleukin 12 administration enhances Th1 activity delays recovery influenza A virus infection mice.
Interleukin 12 alters isotype-restricted antibody answer mice hen eggwhite lysozyme.
Interleukin 12 B7/CD28 interaction synergistically upregulate interleukin 10 production human T cells.
Interleukin 12 autoimmune diabetes.
Interleukin 12 direct cytotoxicity spleen lymphocytes Listeria innocua-phagocyting syngeneic macrophages C57BL/6 BALB/c mice.
Interleukin 12 indomethacin exert synergistic, angiogenesis-dependent anti-tumor activity mice.
Interleukin 12 indomethacin exert synergistic, angiogenesis-dependent antitumor activity mice.
Interleukin 12 innate molecules enhanced mucosal immunity.
Interleukin 12 regulation CD4+ T-cell subset responses murine leishmaniasis.
Interleukin 12 augments liver-associated immunity reduces liver metastases.
Interleukin 12 breaks ultraviolet light stimulated immunosuppression affecting CD8+ CD4+ T cells.
Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune answer peripheral blood mononuclear cells.
Interleukin 12 gene therapy MHC-negative murine melanoma metastases.
Interleukin 12 gene therapy cancer peritumoral injection transduced autologous fibroblasts - Outcome phase I study.
Interleukin 12 gene transfer skin distant tumor site elicits antimetastatic effects equivalent local gene transfer.
Interleukin 12 Takayasu's arteritis - Plasma concentrations relation disease activity.
Interleukin 12 combination anti-interleukin 10 reverse graft prolongation portal venous immunization.
Interleukin 12 induces activation fibrinolysis coagulation humans.
Interleukin 12 expressed actively released Crohn's disease intestinal lamina propria mononuclear cells.
Interleukin 12 produced vivo endotoxemia stimulates synthesis gamma interferon.
Interleukin 12 levels initial phase septic shock purpura children - Relation severity disease.
Interleukin 12 mRNA expression islets correlates beta-cell destruction NOD mice.
Interleukin 12 mediated prevention tumorigenicity murine cell lines derived CD40L transgenic mice.
Interleukin 12 potentiates curative influence vaccine based interleukin 2-transduced tumor cells.
Interleukin 12 primes macrophages nitric oxide production vivo restores depressed nitric oxide production macrophages tumor-bearing mice - Implications antitumor activity interleukin 12 and/or interleukin 2.
Interleukin 12 production monocytes patients psoriasis inhibition ciclosporin A.
Interleukin 12 unmasks HLA class I differences mixed lymphocyte response stimulated interferon gamma production.
Interleukin 12 upregulates release vascular permeability factor peripheral blood mononuclear cells patients lipoid nephrosis.
Interleukin 12- cytokine cancer immunotherapy.
Interleukin 12-augmented T cell proliferation peripheral blood mononuclear cells HIV-seropositive individuals interleukin 12 receptor beta2 upregulation.
Interleukin 12. key modulator immune role.
Interleukin 12. potential link nerve cells immune answer inflammatory disorders.
Interleukin 12 - Adjuvant tumor therapy?
Interleukin 12B gene polymorphism apparent resistance HCV infection.
Interleukin 12B gene polymorphism apparent resistance hepatitis C virus infection.
Interleukin 12p40 required dendritic cell migration T cell priming Mycobacterium tuberculosis infection.
Interleukin 13 interleukin 4 protect bronchoalveolar macrophages productive infection human immunoinsufficiency virus type 1.
Interleukin 13 elicits subset activities close relative interleukin 4.
Interleukin 13 exerts anti-appoptotic effects hypoxic cardionnyocytes Pi3 kinase absence hypertrophic effects.
Interleukin 13 gene transfer liver ischemia reperfusion injury - Role Stat6 TLR4 pathways cytoprotection.
Interleukin 13 increases contractility murine tracheal smooth muscle phosphoinositide 3-kinase p110 delta-dependent mechanism.
Interleukin 13 inhibits macrophage inflammatory protein-1-alpha production human alveolar macrophages monocytes.
Interleukin 13 secreted human head neck tumours modulate growth vitro.
Interleukin 13 suppresses cytokine production stimulates production 15-HETE PBMC - comparison IL-4 IL-13.
Interleukin 13. growth factor Hodgkin lymphoma.
Interleukin 15.
Interleukin 15 activity rectal mucosa inflammatory bowel disease.
Interleukin 15 augments antitumor activity cytokine gene-modified melanoma cell vaccines murine model.
Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8+ T cells
Interleukin 15 controls generation restricted T cell receptor repertoire gamma delta intestinal intraepithelial lymphocytes.
Interleukin 15 expression CNS - Blockade activity prevents glial activation inflammatory injury.
Interleukin 15 induces signals epidermal proliferation ERK PI 3-kinase human epidermal keratinocyte cell line, HaCaT.
Interleukin 15 induction lymphokine-activated killer cell role autologous tumor cells melanoma patient lymphocytes CD18-dependent, perforin-related mechanism.
Interleukin 15 growth factor human thymocytes preferential influence CD8+ cells.
Interleukin 15 potent stimulant intraepithelial lymphocytes.
Interleukin 15 mediates epithelial celiac disease.
Interleukin 15 offers selective protection irinotecan-induced intestinal toxicity preclinical animal model.
Interleukin 15 protects toxicity potentiates antitumour activity 5-fluorouracil combination leucovorin rats bearing colorectal cancer.
Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells
Interleukin 15 stimulates production matrix metalloproteinase-9 tissue inhibitor metalloproteinase-1 human peripheral blood mononuclear cells.
Interleukin 15-dependent crosstalk conventional plasmacytoid dendritic cells essential CpG-induced immune activation.
Interleukin 15-mediated survival natural killer cells determined interactions Bim, Noxa Mcl-1.
Interleukin 15. key disrupted intraepithelial lymphocyte homeostasis lymphomagenesis celiac disease.
Interleukin 15 - Its function inflammation immunity.
Interleukin 15. potential player innate immune answer infection.
Interleukin 16 expression relationship disease activity rheumatoid arthritis.
Interleukin 16 pregnancy, parturition, rupture fetal membranes, microbial invasion amniotic cavity.
Interleukin 16 up-regulated Crohn's disease participates TNBS colitis mice.
Interleukin 17 (IL-17) expression acute respiratory viral infection infants.
Interleukin 17 (IL-17) induces collagenase-3 production human osteoarthritic chondrocytes AP-1 dependent activation - Differential activation AP-1 members IL-17 IL-1beta.
Interleukin 17 stimulated nitric oxide suppresses matrix synthesis protects cartilage matrix breakdown.
Interleukin 17 levels increased juvenile idiopathic arthritis synovial fluid stimulate synovial fibroblasts produce proinflammatory cytokines matrix metalloproteinases.
Interleukin 17 modulates immune answer vaccinia virus infection.
Interleukin 17 synergises with tumour necrosis factor alpha to induce cartilage destruction in vitro
Interleukin 17 nitric oxide-producing cytokine peroxynitrite-independent inhibitory influence proteoglycan synthesis.
Interleukin 17-producing CD4(+) effector T cells develop lineage distinct T helper type 1 2 lineages.
Interleukin 17-producing T helper cells interleukin 17 orchestrate autoreactive germinal center progress autoimmune BXD2 mice.
Interleukin 17 - An gene therapy tool studying cytokine mediated regulation hematopoiesis.
Interleukin 18 (IL-18) levels patients sepsis.
Interleukin 18 (IL-18) upregulation acute rejection kidney allograft.
Interleukin 18 hepatocyte growth factor fulminant hepatic failure adult onset Still's disease.
Interleukin 18 interleukin 18 binding protein - Possible function immunosuppression chronic renal failure.
Interleukin 18 interleukin 1beta production decreased HIV type 1-seropositive hemophiliacs HIV type 1-seropositive nonhemophiliacs.
Interleukin 18 periodontal disease.
Interleukin 18 transforming growth factor beta1 serum patients Graves ophthalmopathy treated corticosteroids.
Interleukin 18 marker disease activity severity patients juvenile idiopathic arthritis.
Interleukin 18 binding protein (IL18-BP) inhibits neointimal hyperplasia balloon injury atherosclerotic rabbit model.
Interleukin 18 hepatic ischemia/reperfusion injury suppressing anti-inflammatory cytokine expression mice.
Interleukin 18 contributes host resistance gamma interferon production mice infested virulent Salmonella typhimurium.
Interleukin 18 enhances Fas ligand expression induces apoptosis Fas-expressing human myelomonocytic KG-1 cells.
Interleukin 18 gene polymorphism potential host-susceptibility factor tuberculosis Chongqing, China.
Interleukin 18 gene polymorphisms predict risk outcome Alzheimers disease.
Interleukin 18 induces synergistic enhancement interferon gamma production mixed murine spleen cell-tumor cell cultures - Role endogenous interleukin 12.
Interleukin 18 induces sequential activation natural killer cells cytotoxic T lymphocytes protect syngeneic mice transplantation Meth A sarcoma.
Interleukin 18 potent proliferative factor intestinal mucosal lymphocytes Crohn's disease.
Interleukin 18 levels reflect severity acute pancreatitis.
Interleukin 18 maintains long-standing inflammation coeliac disease patients.
Interleukin 18 promoter polymorphisms strongly type I diabetes UK population.
Interleukin 18-independent engagement interleukin 18 receptor-alpha required autoimmune inflammation.
Interleukin 18-interferon gamma inducing factor. player tumour immunotherapy?
Interleukin 1 - patterns translation intracellular distribution support alternative secretory mechanisms.
Interleukin 1B interleukin 1RN polymorphisms increased risk gastric carcinoma.
Interleukin 1B gene polymorphism baseline C-reactive protein levels healthy individuals.
Interleukin 1B proinflammatory genotypes protect gastro-oesophageal reflux disease induction corpus atrophy.
Interleukin 1a (-889) gene polymorphism primary intracerebral hemorrhage.
Interleukin 1a interleukin 1b fragment somnogenic.
Interleukin 1a exerts glucose dependent stimulatory inhibitory effects islet cell phosphoinositide hydrolysis insulin secretion.
Interleukin 1a messenger rna virus transformed cells.
Interleukin 1a-induced NFkB Activation Chemokine mRNA Stabilization Diverge IRAK1.
Interleukin 1alpha (IL-1) macrophage colony-stimulating factor (M-CSF) accelerate recovery multiple drug-induced myelosuppression.
Interleukin 1alpha (IL-1alpha) stimulated activation p38 mitogen-activated protein kinase inhibits glucocorticoid receptor role.
Interleukin 1alpha activity peritoneal bone marrow macrophages infested Leishmania major Leishmania donovani vitro.
Interleukin 1alpha alters hippocampal serotonin norepinephrine release open-field behavior Sprague-Dawley animals - Differences Fawn-Hooded animal model depression.
Interleukin 1alpha interleukin 6 protect human neuronal SH-SY5Y cells oxidative damage.
Interleukin 1alpha single-nucleotide polymorphism systemic sclerosis.
Interleukin 1b enhances non-rapid eye movement sleep increases c-Fos protein expression median preoptic nucleus hypothalamus.
Interleukin 1beta (IL-1beta) effect porcine thyroid cells involves ceramide signalling pathway.
Interleukin 1beta (IL-1beta), IL-10, tumor necrosis factor-alpha, cellular proliferation index peripheral blood mononuclear cells patients ankylosing spondylitis.
Interleukin 1beta GABA-transaminase activity rat thymus.
Interleukin 1beta interleukin 6 potentiate retinoic acid-mediated repression human immunoinsufficiency virus type 1 replication macrophages.
Interleukin 1beta interleukin 6, tumor necrosis factor alpha, inhibit insulin-stimulated glycogen synthesis rat hepatocytes.
Interleukin 1beta stimulator rat thymus.
Interleukin 1beta decreases GSH content catalase activity human peritoneal mesothelial cells vitro.
Interleukin 1beta gene polymorphism association severe renal manifestations renal sequelae Henoch-Schonlein purpura.
Interleukin 1beta increases arginine accumulation activates citrulline-NO cycle rat pancreatic beta cells.
Interleukin 1beta induces expression of human herpesvirus 8 encoded genes in BCBL-1 cells.
Interleukin 1beta induces functional prostaglandin E synthase cultured human umbilical vein endothelial cells.
Interleukin 1beta mediated calciotropic activity serum children juvenile rheumatoid arthritis.
Interleukin 1beta mediates influence high D-glucose secretion TNF-alpha mouse uterine epithelial cells.
Interleukin 1beta polymorphisms increase risk hypochlorhydria atrophic gastritis reduce risk duodenal ulcer recurrence Japan.
Interleukin 1beta protects mice Fas-mediated hepatocyte apoptosis death.
Interleukin 1beta, interleukin 6, beta2-microglobulin, transforming growth factor-alpha gingival crevicular fluid human periodontal disease.
Interleukin 1beta, interleukin-6, tumor necrosis factor-alpha endometriotic tissue endometrium.
Interleukin 1beta-converting enzyme (caspase-1) overexpressed adenocarcinoma pancreas.
Interleukin 1beta-secreting cells inflamed gingival tissue adult periodontitis patients.
Interleukin 1beta-stimulated production nitric oxide rat hepatocytes mediated endogenous synthesis interferon gamma.
Interleukin 1il 1 interleukin 2il 2 production patients chronic renal failure.
Interleukin 2.
Interleukin 2 (IL-2) production mitogen induced bovine peripheral blood lymphocytes assay.
Interleukin 2 (IL-2) receptor expression sensitivity diphtheria fusion toxin DAB-389IL-2 cultured hematopoietic cells.
Interleukin 2 4 5 sequentially produced mitogen induced murine spleen cell cultures.
Interleukin 2 Pseudomonas exotoxin (IL2-PE66-4Glu) chimeric protein kills B cells patients myasthenia gravis.
Interleukin 2 potential trigger autoimmunity.
Interleukin 2 abnormalities systemic lupus erythematosus rheumatoid arthritis function overproduction interleukin 2 human autoimmunity?
Interleukin 2 activated mitogen activated nk killer cells highly purified human peripheral blood cell cd3 positive n901 negative cultures.
Interleukin 2 activated cell peripheral blood patients systemic lupus erythematosus.
Interleukin 2 activated human killer cells derived phenotypically heterogeneous precursors.
Interleukin 2 activated human killer lymphocytes lack involvement interferon progress il 2 activated killer lymphocytes.
Interleukin 2 activated big granular lymphocytes cytotoxic efficiency mechanism killing tumor cell lines.
Interleukin 2 activated lymphocytes brain tumor patients comparison preparations generated vitro.
Interleukin 2 activated murine cell lines macrophage lymphoblast lytic activity.
Interleukin 2 activated peripheral blood lymphocytes correlation lytic activity peanut agglutinin receptor expression malignant cells.
Interleukin 2 activated cells lak express cd16 antigen triggered target cell lysis bispecific antibody.
Interleukin 2 activated tumor inhibition vivo depends systemic involvement host immunoreactivity.
Interleukin 2 activates receptor protein kinase.
Interleukin 2 activates bb diabetic rat lymphoid cells cytotoxic islet cells.
Interleukin 2 activates gamma interferon gene newborn mice.
Interleukin 2 activation cytotoxic lymphocytes infiltrating human metastatic melanomas.
Interleukin 2 activited human lymphocytes exhibit enhanced adhesion normal vascular endothelial cells lysis.
Interleukin 2 activity tumor growth interleukin 2 production kinetics uptake responses exogenous interleukin 2.
Interleukin 2 activity chronic active liver diseases answer cells autologous mixed lymphocyte response.
Interleukin 2 activity chronic liver disease influence vitro alpha interferon.
Interleukin 2 activity patients hepatitis modified mtt colorimetric assay.
Interleukin 2 activity human intestinal mucosa mononuclear cells decreased levels inflammatory bowel disease.
Interleukin 2 acts tac positive cloned cell line established patient adult cell leukemia.
Interleukin 2 acutely induces platelet neutrophil endothelial adherence macromolecular leakage.
Interleukin 2 acutely induces protein leakage microcirculation.
Interleukin 2 administered vivo induces growth cultured cells vivo.
Interleukin 2 administered vivo effect interleukin 2 timing cell growth.
Interleukin 2 administration reversible hemodynamic left ventricular dysfunction related septic shock.
Interleukin 2 vivo induction anti erythrocyte auto antibody production nude mice injection rat erythrocytes.
Interleukin 2 mitogenic tac positive lymphocytes human peripheral blood.
Interleukin 2 15 activate Stat3alpha human T lymphocytes.
Interleukin 2 cell hybridoma mp 6 derived cell stimulatory factor act synergistically stimulated proliferation differentiation human chronic lymphocytic leukemia cells.
Interleukin 2 alpha interferon stimulated vitro modulation spontaneous cell mediated cytotoxicity patients cancer uterine cervix undergoing radiotherapy.
Interleukin 2 alpha interferon therapy advanced pulmonary metastases.
Interleukin 2 antibody cell receptor regulate proliferation radiation leukemia virus transformed cell lymphoma.
Interleukin 2 coculture thymic epithelial cells synergistically stimulate prothymocyte differentiation proliferation.
Interleukin 2 concanavalin induce interferon gamma production murine cytolytic cell clone diverse pathways.
Interleukin 2 granulocyte macrophage colony stimulating factor induce growth virulent strain escherichia coli.
Interleukin 2 high dose cisplatin patients metastatic melanoma pilot study.
Interleukin 2 increased natural killer activity mice artificially infested aspergillus niger.
Interleukin 2 interferon alpha cure patients advanced cell lung cancer.
Interleukin 2 interferon alpha modulation lymphocyte non-major histocompatibility-restricted lytic activity glioblastoma patients.
Interleukin 2 interferon alpha-2a improve anti-tumour activity 5-fluorouracil advanced colorectal cancer.
Interleukin 2 interferon gamma activities mononuclear cells regional lymph nodes patients gastric cancer.
Interleukin 2 interferon gamma affect human cells diverse stages activation.
Interleukin 2 interferon gamma sufficient stimulate natural killer activity human cell clones.
Interleukin 2 interferon gamma production follicular lymphomas.
Interleukin 2 interferon gamma recruit diverse subsets human peripheral blood monocytes secrete interleukin 1 beta tumor necrosis factor alpha.
Interleukin 2 interferon production expression interleukin 2 receptors human mononuclear cells induced mumps virus phytohemagglutinin.
Interleukin 2 interferon-gamma augment anticolon antibody dependent cellular cytotoxicity ulcerative colitis.
Interleukin 2 interleukin 15 differentially predispose natural killer cells apoptosis mediated endothelial tumour cells.
Interleukin 2 interleukin 2 inhibitors human serum synovial fluid i. characterization inhibitor mechanism effect.
Interleukin 2 interleukin 2 inhibitors human serum synovial fluid ii. mitogenic stimulation interleukin 2 production interleukin 2 receptor expression rheumatoid arthritis psoriatic arthritis reiter's syndrome.
Interleukin 2 molecular volume cell growth factor cell replacing factors diverse subpopulations human cells.
Interleukin 2 lymphokine activated killer cell therapy examination bolus interleukin 2 continuous infusion interleukin 2 regimen.
Interleukin 2 lymphokine activated killer cell therapy solid tumors examination toxicity manipulation guidelines.
Interleukin 2 lymphokine activated killer cells 15 children advanced metastatic neuroblastoma.
Interleukin 2 lymphokine activated killer cells cure childhood primary hepatocellular carcinoma report.
Interleukin 2 lymphokine activated killer cells cure malignant glioma medical experimental investigations.
Interleukin 2 mitogen driven proliferation human peripheral mononuclear cells kinetic examination.
Interleukin 2 natural killer activity acute type hepatitis.
Interleukin 2 phytohaemagglutinin induce proliferation tunicate cells.
Interleukin 2 phytohemagglutinin activated proliferation human lymphocytes accompanied stimulation phosphoinositide turnover.
Interleukin 2 psoriasis.
Interleukin 2 serum thymic factor enable autologous rosette forming lymphocytes generate helper cyto poisonous functions.
Interleukin 2 soluble interleukin 2 receptor secretion defect vitro newly diagnosed type diabetic patients.
Interleukin 2 syngeneic bone marrow transplantation murine fibrosarcoma model.
Interleukin 2 anti interleukin 2 receptor antibody activation macrophages.
Interleukin 2upregulates receptor induces proliferation resting mononuclear leukocytes absence antigen.
Interleukin 2 inducer proliferation klebsiella induced human cells.
Interleukin 2 augmentation interleukin 1 prostaglandin 2 production.
Interleukin 2 augmentation natural killer cell activity homo sexual men acquired immune insufficiency syndrome.
Interleukin 2 augmentation defective natural killer cell activity patients primary sjogren's syndrome.
Interleukin 2 augments natural killer cell activity.
Interleukin 2 binds gangliosides micelles lipid bilayers.
Interleukin 2 bolus therapy induces selective disappearance peripheral blood lymphocyte subpopulations displaying natural killer activity function cell adhesion endothelium.
Interleukin 2 inhalation local therapy metastatic renal cell carcinoma.
Interleukin 2 stimulate proliferation leukemic cells prolymphocytic leukemia.
Interleukin 2 stimulate suppression human natural killer cell cytotoxicity.
Interleukin 2 prevent reverse antigen stimulated unresponsiveness cloned human lymphocytes.
Interleukin 2 cisplatin 5 fluorouracil patients cell lung head neck carcinomas.
Interleukin 2 counteracts inhibition cytotoxic lymphocytes cholera toxin vitro vivo.
Interleukin 2 defect peripheral blood lung patients sjogren's syndrome.
Interleukin 2 deficiencies rheumatoid arthritis systemic lupus erythematosus.
Interleukin 2 deficiencies interleukin 2 receptors gamma interferon patients aids similar syndromes.
Interleukin 2 insufficiency murine leishmaniasis donovani relation depressed spleen cell responses phyto hem agglutinin.
Interleukin 2 insufficiency murine leishmaniasis donovani relation depressed spleen cell responses phytohemagglutinin.
Interleukin 2 insufficiency usual feature auto immune mice.
Interleukin 2 dependence human natural killer cell activity.
Interleukin 2 dependent activation tumor special cytotoxic lymphocytes vivo.
Interleukin 2 dependent alloreactive cell line special suppressor role.
Interleukin 2 dependent control disease progress spontaneously diabetic bb rats.
Interleukin 2 dependent natural killer cell lines patients primary cell immuno deficiencies.
Interleukin 2 dependent phosphorylation interleukin 2 receptors cell membrane proteins.
Interleukin 2 dependent cell line acquires responsiveness phorbol myristate acetate lipopolysaccharide long term culture.
Interleukin 2 dependent lymphocytes identification investigation inherited metabolic disorders.
Interleukin 2 determinations monitoring renal allograft.
Interleukin 2 differentially affects proliferation hormone dependent hormone independent human breast cancer cell line vitro vivo.
Interleukin 2 differentially regulates interleukin 2 receptors murine cloned cytolytic helper cells.
Interleukin 2 diphtheria toxin fusion protein prolongs murine islet cell engraftment.
Interleukin 2 increases albumin permeability bovine human vascular endothelium vitro.
Interleukin 2 stimulate murine cells secrete immuno globulin.
Interleukin 2 stimulate phosphatidylinositol hydrolysis activated cells.
Interleukin 2 promote vitro vivo proliferation growth human acute leukemia cells myeloid lymphoid origin.
Interleukin 2 down-modulates macrophage colony-stimulating factor receptor murine macrophages.
Interleukin 2 driven nuclear translocation prolactin cloned lymphocytes.
Interleukin 2 driven lymphocyte proliferation dependent surface antigen distinct interleukin 2 receptor demands inhibition cell proliferation mono clonal antibody 5c 3.
Interleukin 2 enhanced interferon gamma enhanced natural cytotoxic activity examination function diverse lymphoid subsets implications activation routes.
Interleukin 2 enhancement lymphokine secretion lymphocytes examination established clones primary limiting dilution micro cultures.
Interleukin 2 enhancement monoclonal antibody mediated cellular cytotoxicity human melanoma.
Interleukin 2 enhancement veto suppressor cell role cell depleted bone marrow vitro vivo.
Interleukin 2 enhances biopterins catecholamines production adoptive immunotherapy cancers.
Interleukin 2 enhances chick rat sympathetic sensory neurite outgrowth.
Interleukin 2 enhances cytotoxic cell role vitro cell depleted marrow transplantation.
Interleukin 2 enhances natural killer cell activity induction gamma interferon.
Interleukin 2 enhances natural killing normal lymphocytes.
Interleukin 2 enhances natural killing varicella zoster virus infested targets.
Interleukin 2 enhances special nonspecific immune responses experimental Chagas disease.
Interleukin 2 enhances special nonspecific immune responses experimental chagas disease.
Interleukin 2 enhances efficiency immunotoxins cure mice ascitic tumors.
Interleukin 2 enhances natural killer cell activity acquired immunoinsufficiency syndrome patients gamma interferon independent mechanism.
Interleukin 2 enhances release endothelin 1 rat mesenteric artery.
Interleukin 2 enhances translocation escherichia coli intestines organs.
Interleukin 2 enhances wound healing rats.
Interleukin 2 exerts autocrine stimulation murine T-cell leukaemia growth.
Interleukin 2 expanded tumor infiltrating lymphocytes human renal cell cancer isolation characterization antitumor activity.
Interleukin 2 expression tumor cells alters immune answer tumor microenvironment.
Interleukin 2 functions interleukin 2 binding molecules cells.
Interleukin 2 gene therapy prostate cancer - Phase I medical experiment basic biology.
Interleukin 2 gene therapy residual disease mice carrying tumours stimulated HPV 16.
Interleukin 2 gene therapy surgical minimal residual tumour disease - Characterization cytolytic effector cells tumour progressors regressors.
Interleukin 2 gene transcription regulated Ikaros-induced histone acetylation anergic T cells.
Interleukin 2 il 2 activity variation patients nasopharyngeal carcinoma.
Interleukin 2 il 2 il 2 activated bone marrow transplantation assessment medical perspective.
Interleukin 2 il 2 infusion induces oxygen free radicals release human polymorphonucleates pmns lymphocytes.
Interleukin 2 il 2 relationships cancer similar immunoinsufficiency vitro answer exogenous il 2 pha activated pha activated peripheral blood mononuclear cells cancer patients.
Interleukin 2 immediately autologous bone marrow transplantation acute lymphoblastic leukemia. phase I study.
Interleukin 2 immunotherapy resection residual renal cell carcinoma.
Interleukin 2 immunotherapy children.
Interleukin 2 immunotherapy children neuroblastoma high dose chemotherapy autologous bone marrow transplantation.
Interleukin 2 association increasing doses interferon gamma patients advanced cancer.
Interleukin 2 bone marrow transplantation preclinical investigations.
Interleukin 2 cell mediated immune responses.
Interleukin 2 combination interferon alpha disseminated malignant melanoma advanced renal cell carcinoma phase ii study.
Interleukin 2 liposomes increased intravenous potency pulmonary toxicity rat.
Interleukin 2 rheumatoid arthritis production answer interleukin 2 rheumatoid synovial fluid synovial tissue peripheral blood.
Interleukin 2 scleroderma correlation serum degree extent skin involvement disease duration.
Interleukin 2 ontogeny human lymphoid tissues.
Interleukin 2 peripheral blood behcet disease.
Interleukin 2 vivo production answer interleukin 2 lymphoid organs undergoing primary immune answer heterologous erythrocytes.
Interleukin 2 inception impact implications.
Interleukin 2 increases T lymphocyte membrane mobility rise cytosolic calcium concentration.
Interleukin 2 increases protection experimental rabies.
Interleukin 2 increases lymphocyte membrane mobility rise cytosolic calcium concentration.
Interleukin 2 increases antibody answer patients receiving autologous intralymphatic tumor cell vaccine immunotherapy.
Interleukin 2 increases oxidative activity induces migration murine polymorphonuclear leukocytes vitro.
Interleukin 2 independent interleukin 2 receptor independent proliferation cell lines adult cell leukemia lymphoma patients.
Interleukin 2 independent stimulation rabbit chondrocyte collagenase prostaglandin 2 production interleukin 1 factor.
Interleukin 2 stimulated activation natural killer activity spleen cells young mice.
Interleukin 2 stimulated activation natural killer cells rats mice comparative study.
Interleukin 2 stimulated neopterin stimulated neopterin release peripheral blood mononuclear cells.
Interleukin 2 stimulated chemotaxis human lymphocytes.
Interleukin 2 stimulated cytotoxicity chediak higashi lymphocytes.
Interleukin 2 stimulated cytotoxicity renal cell carcinoma synergistic effects interleukin 2 interferon gamma.
Interleukin 2 stimulated cytotoxicity renal cell carcinoma in vitro enhancement natural killer cell activity.
Interleukin 2 stimulated decrease buoyant density cytotoxic cells relation proliferation.
Interleukin 2 stimulated dna synthesis immunoglobulin secretion resting human tonsillar cells effects protein kinase activation.
Interleukin 2 stimulated immune cytotoxic lymphocytes syngeneic lymphoma el 4 primary mixed culture.
Interleukin 2 stimulated increase monoclonal cell lymphocytosis vivo interleukin 2 effect?
Interleukin 2 stimulated killer cell activity epstein barr virus immortalized human cells.
Interleukin 2 stimulated leukocyte adhesion normal tumor microvascular endothelium vivo inhibition dextran sulfate implications vascular leak syndrome.
Interleukin 2 stimulated lung injury mediated oxygen free radicals.
Interleukin 2 stimulated lung permeability mediated leukotriene 4.
Interleukin 2 stimulated lymphocyte proliferation independent increases cytosolic free calcium concentrations.
Interleukin 2 stimulated mitogenesis human peripheral blood lymphocytes function accessory cells.
Interleukin 2 stimulated production interferon gamma resting human cells big granular lymphocytes demand accessory cell factors including interleukin 1.
Interleukin 2 stimulated proliferation cd4 cd8 human thymocytes vitro expression cd3 cd8 antigens cytolytic activity.
Interleukin 2 stimulated protein phosphorylation dephosphorylation human adherent peripheral blood mononuclear cells initial phosphorylation 75 kda proteins.
Interleukin 2 stimulated recovery natural killer activity stress.
Interleukin 2 stimulated systemic toxicity induction mediators immunopharmacologic intervention.
Interleukin 2 stimulated tumor necrosis factor alpha gene expression human alveolar macrophages blood monocytes.
Interleukin 2 induces fast increases ornithine decarboxylase messenger rna cloned murine lymphocytic cell line.
Interleukin 2 induces transient downregulation protein phosphatase 1 2A activity human T cells.
Interleukin 2 induces activation proliferation normal human peripheral blood mononuclear cells.
Interleukin 2 induces appearance lgl leu11 positive k562 lytic cells leu11 negative density peripheral blood mononuclear cell population.
Interleukin 2 induces growth maturation lectin reactive lyt 2 positive lyt 2 negative precursor cells regulates cytolytic potential effector cells.
Interleukin 2 induces cytotoxic activity lymphocytes regional axillary nodes breast cancer patients.
Interleukin 2 induces gamma interferon production participation macrophages natural killer cells.
Interleukin 2 induces human acute lymphocytic leukemia cells manifest lymphokine activated killer lak cytotoxicity.
Interleukin 2 induces interferon alpha beta production mouse bone marrow cells.
Interleukin 2 induces motility human lymphocytes mobility.
Interleukin 2 induces profound reversible cholestasis detailed examination treated cancer patients.
Interleukin 2 induces proliferation normal resting human cells absence external stimulation.
Interleukin 2 induces proliferation lymphocyte mutants lacking protein kinase.
Interleukin 2 induces fast phosphorylation 85 kilodalton protein permeabilized lymphocytes.
Interleukin 2 induces synthesis polypeptides interleukin 2 dependent cell line transcription translation.
Interleukin 2 induces cell dependent immunoglobulin production human cells.
Interleukin 2 induces tumor necrosis factor gene expression vivo.
Interleukin 2 inducible killer activity regulation blood monocytes autologous lymphocytes lung cancer patients.
Interleukin 2 induction acth secretion presence interleukin 2 receptor alpha chain molecule pituitary cells.
Interleukin 2 induction antigen nonspecific suppressor cells.
Interleukin 2 induction cytochrome P450-linked monooxygenase systems rat liver microsomes.
Interleukin 2 induction hapten special cytolytic cells nude mice.
Interleukin 2 induction interferon gamma messenger rna synthesis.
Interleukin 2 induction proliferation resting T lymphocytes requires contact monocytes.
Interleukin 2 induction cell 1 progression myb expression.
Interleukin 2 infusion induces hemopoietic growth factors modifies marrow regeneration chemotherapy autologous marrow transplantation.
Interleukin 2 inhibition oligodendrocyte progenitor cell proliferation depends expression tac receptor.
Interleukin 2 inhibitor synovial fluid.
Interleukin 2 inhibits antigen induced lymphokine synthesis helper cells inhibiting calcium dependent signalling.
Interleukin 2 inhibits growth fibroblasts derived human bone marrow.
Interleukin 2 inhibits vitro granulocyte macrophage colony structure.
Interleukin 2 inhibits migration stimulates respiratory burst degranulation human neutrophils vitro.
Interleukin 2 inhibits interleukin 4 stimulated human ige igg4 secretion vitro.
Interleukin 2 inhibits replication human herpesvirus 6 mature thymocytes.
Interleukin 2 injected tumor draining lymph nodes head neck cancer.
Interleukin 2 interacts myeloid growth factors serum-free long-term bone marrow culture.
Interleukin 2 interferon lymphotoxin renal transplant recipients.
Interleukin 2 interleukin 2 receptor gamma interferon synthesis peripheral blood mononuclear cells chronic hepatitis delta virus infection.
Interleukin 2 interleukin 2 receptor interferon gamma synthesis messenger rna expression phorbol myristate acetate calcium ionophore 23187 induced cells elderly humans.
Interleukin 2 interleukin 2 receptor interleukin 4 levels elevated sera patients periodontal disease.
Interleukin 2 interleukin 4 independent helper cell generation vitro antigenic stimulation mouse spleen cells presence cyclosporin.
Interleukin 2 potent inhibitor leydig cell steroidogenesis.
Interleukin 2 proliferative signal cells autoimmune mice.
Interleukin 2 sufficient growth differentiation lectin induced cytolytic lymphocyte precursors.
Interleukin 2 sufficient helper constituent activation cyto poisonous lymphocytes synergizes late helper influence irradiated area incompatible stimulator cells.
Interleukin 2 sufficient continuous growth cloned natural killer cyto poisonous cell lines.
Interleukin 2 required induction erythrocyte special antibody responses human lymphocyte cultures.
Interleukin 2 production malignant tumor growth influence human tumor biopsies.
Interleukin 2 leads dose-dependent expression alpha chain IL-2 receptor CD25-negative T lymphocytes absence exogenous antigenic stimulation.
Interleukin 2 levels serum cerebrospinal fluid multiple sclerosis patients.
Interleukin 2 material human epidermis ligand human interleukin 2 receptor 55 kd alpha chain.
Interleukin 2 lymphokine activated killer cell therapy hodgkin's lymphoma hodgkin's disease.
Interleukin 2 maintains biologic stability sterility extended time.
Interleukin 2 play inhibitory contributory function tumor expansion experimental findings medical perspective.
Interleukin 2 mediated events gamma interferon production calcium dependent 1 site.
Interleukin 2 mediated immune interferon production human cells cell subsets.
Interleukin 2 mediated induction lytic activity cloned murine cytotoxic lymphocyte line.
Interleukin 2 mediated regulation mitogen activated cell reactivity diverse lymphoid sources patients squamous cells carcinoma oral cavity.
Interleukin 2 mediates alteration t200 antigen expressed activated lymphocytes.
Interleukin 2 mediates p72-syk activation peripheral blood lymphocytes.
Interleukin 2 messenger rna expression lymphokine production dna synthesis glutathione depleted cells.
Interleukin 2 messenger rna induction human lymphocytes examination synergistic influence calcium ionophore 23187 phorbol ester.
Interleukin 2 messenger rna induction human lymphocytes examination synergistic influence phorbol ester phytohemagglutinin.
Interleukin 2 modulates intestinal epithelial cell role vitro.
Interleukin 2 modulates expression lymphocyte role antigen lfa 1 p15095 generation lymphokine activated killer lak cells.